BlueRock Therapeutics announced a new achievement in regenerative medicine – its employees managed to introduce modified neurons into the human brain to stimulate the production of dopamine. A year ago, this procedure was performed on 12 patients with overt symptoms of Parkinson’s disease. The success lies in the fact that during this time the alien fragments were not rejected by the organisms of the subjects.
Ideally, scientists would like to be able to simply replace degraded cells with lab-created analogs with new functions. This will increase the production of dopamine, which will help
stop or even cure Parkinson’s disease. Indeed, the subjects experienced fewer bouts of helplessness, incapacity than before the start of participation in the experiment.
Unfortunately, alien neurons never took root in the brain, did not become one with it. Therefore, it is not yet necessary to say that the body began to cope with this disease. The measure is rather temporary – implanted neurons hold back the development of Parkinson’s disease, but nothing more. The company will continue to work on finding the optimal composition of the implantable material.